These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32893519)

  • 1. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
    Hwang YJ; Park JH; Cho DH
    J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Far-Infrared Irradiation Decreases Proliferation in Basal and PDGF-Stimulated VSMCs Through AMPK-Mediated Inhibition of mTOR/p70S6K Signaling Axis.
    Hwang YJ; Park JH; Cho DH
    J Korean Med Sci; 2023 Oct; 38(41):e335. PubMed ID: 37873631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
    Osman I; Segar L
    Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AMPK/proteasome/MLCK degradation signaling axis by telmisartan inhibits VSMC contractility and vessel contraction.
    Hwang YJ; Cho DH
    Biochem Biophys Res Commun; 2020 Apr; 524(4):853-860. PubMed ID: 32046856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR.
    Zhao Y; Shang F; Shi W; Zhang J; Zhang J; Liu X; Li B; Hu X; Wang L
    Cardiology; 2019; 143(1):1-10. PubMed ID: 31307032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid decreases vascular smooth muscle cell proliferation via protein phosphatase 2A-mediated p70 S6 kinase inhibition.
    Lee H; Hwang YJ; Park JH; Cho DH
    Biochem Biophys Res Commun; 2022 May; 606():94-99. PubMed ID: 35339758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
    Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
    Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
    Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
    Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
    Shawky NM; Segar L
    Pharmacol Res; 2017 May; 119():251-264. PubMed ID: 28212891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
    Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
    Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway.
    Pei X; Li X; Chen H; Han Y; Fan Y
    DNA Cell Biol; 2016 Aug; 35(8):426-33. PubMed ID: 27064837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.
    Kim JS; Kim IK; Lee SY; Song BW; Cha MJ; Song H; Choi E; Lim S; Ham O; Jang Y; Hwang KC
    Cell Biol Int; 2012 Mar; 36(3):305-10. PubMed ID: 22050182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan-induced PPARγ activity attenuates lipid accumulation in VSMCs via induction of autophagy.
    Li BH; Liao SQ; Yin YW; Long CY; Guo L; Cao XJ; Liu Y; Zhou Y; Gao CY; Zhang LL; Li JC
    Mol Biol Rep; 2015 Jan; 42(1):179-86. PubMed ID: 25249228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nkx2-3 induces autophagy inhibiting proliferation and migration of vascular smooth muscle cells via AMPK/mTOR signaling pathway.
    Zheng H; Zhai W; Zhong C; Hong Q; Li H; Rui B; Zhu X; Que D; Feng L; Yu B; Huang G; Yin J; Li J; Yan J; Yang P
    J Cell Physiol; 2021 Nov; 236(11):7342-7355. PubMed ID: 33928642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.
    Sung JY; Choi HC
    Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
    Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin inhibits PDGF-induced mesangial cell proliferation: regulation of mammalian target of rapamycin-mediated survival pathway by adenosine 5-monophosphate-activated protein kinase.
    Su YX; Deng HC; Zhang MX; Long J; Peng ZG
    Horm Metab Res; 2012 Jan; 44(1):21-7. PubMed ID: 22105511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
    Han S; Roman J
    Mol Cancer Ther; 2006 Feb; 5(2):430-7. PubMed ID: 16505118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR.
    Lee KY; Lee DH; Choi HC
    Clin Hypertens; 2015; 22():2. PubMed ID: 26893937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.